EDURANT

Medicinal product

(Invented) name

EDURANT

Active substance (s)

Rilpivirinas

Strength

2,5 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AG05, Rilpivirine

Marketing authorisation holder

Janssen-Cilag International N.V., Belgija

Date of authorisation

2011-11-28

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Rilpivirinas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115567	101674	1101674	dalomoji lizdinė plokštelė	N90×1		Receptinis	EU/1/11/736/002	Nepradėtas tiekti	-	-	No	-	-

Stadijos

Data	Stadija
2011-11-28	Registruotas